Moberg Pharma AB (OSTO:MOB) Short-Term Capital Lease Obligation : kr1.29 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Moberg Pharma AB Short-Term Capital Lease Obligation?

Moberg Pharma AB's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr1.29 Mil.

Moberg Pharma AB's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 (kr0.98 Mil) to Dec. 2023 (kr1.27 Mil) and increased from Dec. 2023 (kr1.27 Mil) to Mar. 2024 (kr1.29 Mil).

Moberg Pharma AB's annual Short-Term Capital Lease Obligation declined from Dec. 2021 (kr2.70 Mil) to Dec. 2022 (kr2.12 Mil) and declined from Dec. 2022 (kr2.12 Mil) to Dec. 2023 (kr1.27 Mil).

Moberg Pharma AB Short-Term Capital Lease Obligation Historical Data

The historical data trend for Moberg Pharma AB's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moberg Pharma AB Short-Term Capital Lease Obligation Chart

Moberg Pharma AB Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

2.70

2.12

1.27

Moberg Pharma AB Quarterly Data
	Mar19	Jun19	Sep19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															1.74	1.64	0.98	1.27	1.29

Moberg Pharma AB Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Moberg Pharma AB Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Moberg Pharma AB's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Moberg Pharma AB (OSTO:MOB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Moberg Pharma AB (OSTO:MOB) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

MB8:Germany

Address

Gustavslundsvagen 42, 5th Floor, Bromma, Stockholm, SWE, SE-167 51

Website

https://www.mobergpharma.se

Moberg Pharma AB is a Swedish pharmaceutical company focused on commercializing proprietary innovations based on drug delivery of proven compounds. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. The Company's main product, MOB-015, is a novel topical treatment for onychomycosis It has a single operating segment, the development, and commercialization of medical products. Moberg Pharma has commercial agreements with partners in Europe and Canada, among others.